Clinical Trials

24 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06127303 2025-09-05

Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC

54 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07154082 2025-09-04

Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma

27 enrolled

Carcinoma, Hepatocellular

NCT07130240 2025-08-19

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

40 enrolled

Hyperthermia, Gastrointestinal Neoplasms

NCT03623646 2025-08-08

CITHARE

Phase 2 Completed

11 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07014202 2025-07-30

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

224 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06811844 2025-07-01

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

208 enrolled

Head & Neck

Pathologic Complete Response, Nasopharyngeal Neoplasms

NCT06356584 2025-06-26

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

62 enrolled

Colorectal Neoplasms

NCT07015489 2025-06-11

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

Phase 2 Completed

44 enrolled

ESCC

NCT06823479 2025-05-29

MATISSE 2

41 enrolled

DermatologicHead & Neck

Cutaneous Squamous Cell Carcinoma (CSCC)

NCT06908668 2025-04-03

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

170 enrolled

Breast

HER2-Negative Locally Advanced Breast Cancer

NCT06878222 2025-04-01

Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC

35 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06849167 2025-02-27

Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC

63 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06691594 2025-02-20

Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy

20 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04724928 2025-01-15

EFFORT-MIBC

156 enrolled

Muscle-Invasive Bladder Carcinoma

NCT06718309 2024-12-05

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

40 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06700421 2024-11-22

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

32 enrolled

Radiation Pneumonitis

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

25 enrolled

Pancreatic Neoplasms

NCT06199882 2024-10-15

SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

Phase 2 Suspended

34 enrolled

Biliary Tract Carcinoma

NCT06599827 2024-09-19

iMHRT-LARC

54 enrolled

Rectal Neoplasms

NCT05229614 2024-08-21

ICONIC

DermatologicGenitourinaryHead & NeckThoracic

27 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma

NCT02949843 2024-06-28

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Phase 2 Terminated

19 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT06359275 2024-06-25

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

81 enrolled